upcoming advances in prostate cancer: parpi, cdk4/6, lutetium psma therapy & car-t approaches
Published 3 years ago • 130 plays • Length 3:53Download video MP4
Download video MP3
Similar videos
-
6:45
177lu-psma-617 for prostate cancer: therap, vision, upfrontpsma and lutectomy
-
1:24
luparp: 177lu-psma-617 and parp inhibitor combination for prostate cancer
-
1:26
current standards and future prospects for the treatment of hormone refractory prostate cancer
-
14:37
lupsma: the newest treatment class for advanced prostate cancer
-
0:45
treatment sequencing for metastatic castration-resistant prostate cancer
-
2:25
phase i trial of arx517, an anti-psma adc, in mcrpc
-
2:30
parp inhibitors plus novel endocrine agents for patients with metastatic prostate cancer
-
1:45
psma-targeted therapies in clinical development show promise for prostate cancer
-
5:15
rucaparib and olaparib: two new treatments approved for advanced prostate cancer | pcri
-
51:23
parpi: precision medicine in advanced prostate cancer (2023)
-
0:18
the #innovate trial is for patients with node-positive #prostatecancer.
-
1:27:31
new era of lutetium-psma post approval: perspectives, challenges & future
-
11:58
optimal treatment of clinically node-positive prostate cancer in the psma pet/ct era
-
24:08
prostate cancer updates: advances in precision medicine and parp inhibitors
-
2:25
new hope for treatment-resistant metastatic prostate cancer
-
16:29
precision medicine and the future of prostate cancer
-
1:52
prostate cancer research: is there a future for immunotherapy?
-
16:13
advancements in the diagnosis and treatment of patients with prostate cancer
-
51:09
fapi theranostics for prostate cancer